diazepam has been researched along with ondansetron in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (4.76) | 18.7374 |
1990's | 23 (54.76) | 18.2507 |
2000's | 6 (14.29) | 29.6817 |
2010's | 11 (26.19) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Artursson, P; Mateus, A; Matsson, P | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Heaton, M; Marsden, CA; Upton, N; Wright, IK | 1 |
Barnes, NM; Cheng, CH; Costall, B; Ge, J; Naylor, RJ | 1 |
Mathew, RJ; Wilson, WH | 1 |
Borsini, F; D'Aranno, V; Lecci, A; Mancinelli, A; Meli, A; Stasi, MA; Volterra, G | 1 |
Rodgers, RJ; Shepherd, JK | 1 |
Costall, B; Kelly, ME; Naylor, RJ; Onaivi, ES; Tyers, MB | 1 |
Costall, B; Jones, BJ; Kelly, ME; Naylor, RJ; Oakley, NR; Onaivi, ES; Tyers, MB | 1 |
Cheng, CH; Costall, B; Ge, J; Naylor, RJ | 1 |
Blaney, FE; Edge, C; Phippen, RW | 1 |
O'Hanlon, JF; Swijgman, HF; Uiterwijk, MM; van Veggel, LM; Vermeeren, A | 1 |
Baxter, GS; Blackburn, TP; Kennett, GA; King, FD; Piper, DC; Sanger, GJ; Thomas, DR; Upton, N; Wood, MD | 1 |
Bill, DJ; Dourish, CT; Fletcher, A; Grewal, SS; Shepherd, JK | 1 |
Dooley, DJ; Klamt, I | 1 |
Misawa, M; Mizoguchi, H; Suzuki, T | 1 |
Anthony, EW; Nevins, ME | 1 |
Misawa, M; Mizoguchi, H; Shirayama, N; Suzuki, T; Tsuda, M; Yoshiike, M | 1 |
Costall, B; Naylor, RJ | 1 |
Becker, C; Benoliel, JJ; Hamon, M; Nevo, I | 1 |
Bradbury, A; Houston, JB; Worboys, PD | 1 |
Kulkarni, SK; Roychoudhury, M | 1 |
Evoniuk, G; Freeman, AM; Freeman, KL; Hearne, EM; Norris, GT; Roggero, BA; Rush, JA; Webb, PB; Westphal, JR | 1 |
Barnes, NM; Costall, B; Ge, J; Naylor, RJ | 1 |
Castejón, AM; Cubeddu, LX | 1 |
De Leo, V; Ditto, A; la Marca, A; Morgante, G | 1 |
Kaneko, T; Kikusui, T; Tonohiro, T | 1 |
Bhargava, VK; Handu, SS; Karan, RS; Saha, L | 1 |
Coboeken, K; Dallmann, A; Eissing, T; Hempel, G; Ince, I | 1 |
2 review(s) available for diazepam and ondansetron
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The pharmacology of the 5-HT4 receptor.
Topics: 4-Aminobenzoic Acid; 5-Hydroxytryptophan; Animals; Anxiety; Arousal; Brain; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Indoles; Mice; Neural Inhibition; Ondansetron; para-Aminobenzoates; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Tropisetron | 1993 |
4 trial(s) available for diazepam and ondansetron
Article | Year |
---|---|
Evaluation of the effects of diazepam and an experimental anti-anxiety drug on regional cerebral blood flow.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety Disorders; Cerebral Cortex; Diazepam; Drugs, Investigational; Female; Humans; Imidazoles; Male; Middle Aged; Ondansetron; Personality Inventory; Radionuclide Imaging; Regional Blood Flow; Xenon Radioisotopes | 1991 |
Anxiolytics' effects on the actual driving performance of patients and healthy volunteers in a standardized test. An integration of three studies.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Attention; Automobile Driving; Cross-Over Studies; Diazepam; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Humans; Imidazoles; Lorazepam; Middle Aged; Naphthyridines; Ondansetron; Piperazines; Psychomotor Performance; Pyridines; Sulfur Compounds | 1995 |
Efficacy of ondansetron in the treatment of generalized anxiety disorder.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Diazepam; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Ondansetron; Pilot Projects; Psychiatric Status Rating Scales; Serotonin Antagonists; Treatment Outcome | 1997 |
Evaluation of treatment of hyperemesis gravidarum using parenteral fluid with or without diazepam. A randomized study.
Topics: Adult; Antiemetics; Diazepam; Female; Gestational Age; Humans; Hydrocortisone; Hyperemesis Gravidarum; Ondansetron; Parenteral Nutrition; Placebos; Pregnancy; Vitamins | 1999 |
36 other study(ies) available for diazepam and ondansetron
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
A high-throughput cell-based method to predict the unbound drug fraction in the brain.
Topics: Animals; Brain; Dialysis; HEK293 Cells; High-Throughput Screening Assays; Humans; Pharmaceutical Preparations; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze.
Topics: Adrenergic alpha-Antagonists; Animals; Anti-Anxiety Agents; Diazepam; Dioxanes; Idazoxan; Imidazoles; Male; Ondansetron; Pyrimidines; Rats; Ritanserin; Serotonin; Serotonin Antagonists; Substance Withdrawal Syndrome | 1992 |
Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Buspirone; Diazepam; Dose-Response Relationship, Drug; Frontal Lobe; Hydroxyindoleacetic Acid; Male; Ondansetron; Rats; Serotonin; Serotonin Antagonists; Stereoisomerism | 1992 |
Effect of serotoninergic drugs on stress-induced hyperthermia (SIH) in mice.
Topics: 5,7-Dihydroxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Body Temperature Regulation; Buspirone; Diazepam; Ergolines; Fenclonine; Fever; Flumazenil; Imidazoles; Male; Mice; Ondansetron; Piperazines; Piperidines; Ritanserin; Serotonin; Serotonin Antagonists; Stress, Psychological; Tetrahydronaphthalenes | 1990 |
8-OH-DPAT specifically enhances feeding behaviour in mice: evidence from behavioural competition.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Avoidance Learning; Competitive Behavior; Conflict, Psychological; Diazepam; Dose-Response Relationship, Drug; Feeding Behavior; Imidazoles; Male; Mice; Mice, Inbred DBA; Naphthalenes; Ondansetron; Social Behavior; Tetrahydronaphthalenes | 1990 |
Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse.
Topics: Animals; Brain; Diazepam; Exploratory Behavior; Imidazoles; Indoles; Male; Mice; Ondansetron; Receptors, Serotonin; Serotonin Antagonists; Tropisetron | 1989 |
The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam.
Topics: Animals; Anti-Anxiety Agents; Avoidance Learning; Buspirone; Darkness; Diazepam; Flumazenil; Imidazoles; Light; Male; Mice; Mice, Inbred Strains; Ondansetron; Rats; Rats, Inbred Strains; Serotonin Antagonists; Social Behavior; Substance Withdrawal Syndrome; Time Factors | 1989 |
The profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5-HT release in the frontal cortex of freely-moving rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cerebral Cortex; Clonidine; Dialysis; Diazepam; Drug Interactions; Extracellular Space; Frontal Lobe; Hydroxyindoleacetic Acid; Male; Ondansetron; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Yohimbine | 1993 |
Molecular surface comparison. 2. Similarity of electrostatic vector fields in drug design.
Topics: Anti-Anxiety Agents; Benzamides; Benzazepines; Bridged Bicyclo Compounds, Heterocyclic; Carbolines; Diazepam; Drug Design; Electricity; GABA-A Receptor Agonists; Granisetron; Indoles; Isomerism; Molecular Conformation; Ondansetron; Pharmaceutical Preparations; Protein Binding; Pyrazoles; Pyridazines; Receptors, Drug; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Structure-Activity Relationship; Surface Properties; Triazolam; Tropisetron | 1995 |
BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like properties.
Topics: Animals; Anti-Anxiety Agents; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Diazepam; Esophagus; Guinea Pigs; Heart; Ileum; In Vitro Techniques; Indoles; Interpersonal Relations; Ion Channel Gating; Male; Ondansetron; Peripheral Nervous System; Piperazines; Rabbits; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Serotonin; Reflex; Serotonin Antagonists | 1993 |
Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Chlordiazepoxide; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Ondansetron; Piperazines; Posture; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists | 1994 |
Differential profile of the CCKB receptor antagonist CI-988 and diazepam in the four-plate test.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Diazepam; Dose-Response Relationship, Drug; Electroshock; Exploratory Behavior; Flumazenil; Indoles; Male; Meglumine; Mice; Ondansetron; Receptors, Cholecystokinin | 1993 |
Effects of serotonergic anxiolytics on physical dependence on diazepam in mice.
Topics: Animals; Anti-Anxiety Agents; Buspirone; Carbolines; Diazepam; Drug Synergism; Epilepsy, Tonic-Clonic; Male; Mice; Mice, Inbred ICR; Ondansetron; Receptors, GABA-A; Serotonin; Substance-Related Disorders | 1993 |
Antagonists at the serotonin-3 receptor can reduce the fear-potentiated startle response in the rat: evidence for different types of anxiolytic activity?
Topics: Animals; Anti-Anxiety Agents; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Buspirone; Diazepam; Fear; Granisetron; Male; Ondansetron; Rats; Reflex, Startle; Serotonin Antagonists | 1994 |
Potentiation of physical dependence on diazepam by ondansetron in rats.
Topics: Animals; Body Weight; Diazepam; Drug Synergism; Male; Ondansetron; Rats; Rats, Inbred F344; Substance Withdrawal Syndrome; Substance-Related Disorders | 1994 |
Stress- and yohimbine-induced release of cholecystokinin in the frontal cortex of the freely moving rat: prevention by diazepam but not ondansetron.
Topics: Administration, Inhalation; Animals; Cholecystokinin; Chromatography, High Pressure Liquid; Diazepam; Ether; Frontal Lobe; Male; Ondansetron; Potassium; Rats; Rats, Sprague-Dawley; Restraint, Physical; Stress, Physiological; Yohimbine | 1996 |
Kinetics of drug metabolism in rat liver slices. III. Relationship between metabolic clearance and slice uptake rate.
Topics: Animals; Caffeine; Diazepam; In Vitro Techniques; Liver; Male; Ondansetron; Pharmacokinetics; Phenytoin; Rats; Rats, Sprague-Dawley; Tolbutamide | 1997 |
Antianxiety profile of ondansetron, a selective 5-HT3 antagonist, in a novel animal model.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Conflict, Psychological; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Female; Flumazenil; GABA Modulators; Male; Mice; Mice, Inbred BALB C; Ondansetron; Serotonin Antagonists | 1997 |
Effect of aversive stimulation on 5-hydroxytryptamine and dopamine metabolism in the rat brain.
Topics: Animals; Anti-Anxiety Agents; Brain Chemistry; Catecholamines; Diazepam; Dopamine; Environment; Indoles; Interpersonal Relations; Light; Male; Motor Activity; Ondansetron; Rats; Serotonin; Serotonin Antagonists | 1997 |
Level of punishment determines anticonflict activity of ondansetron in pigeons: comparison with buspirone and diazepam.
Topics: Animals; Anti-Anxiety Agents; Buspirone; Columbidae; Conflict, Psychological; Diazepam; Drug Evaluation, Preclinical; Electroshock; Ondansetron; Punishment; Serotonin Antagonists | 1998 |
The allocentric place discrimination task is selectively and highly dependent on the central muscarinic system in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Brain; Diazepam; Discrimination Learning; Dizocilpine Maleate; Flumazenil; Male; Mecamylamine; Ondansetron; Rats; Rats, Inbred F344; Receptors, Muscarinic; Scopolamine; Swimming | 2000 |
EFFECT OF 5-HT3 ANTAGONIST ONDANSETRON ON WRAP-RESTRAINT AND CONDITIONED EMOTIONAL STRESS INDUCED DEFECATION.
Topics: Animals; Atropine; Conditioning, Psychological; Defecation; Diazepam; Dose-Response Relationship, Drug; Male; Ondansetron; Rats; Rats, Wistar; Restraint, Physical; Serotonin 5-HT3 Receptor Antagonists; Stress, Psychological | 1999 |
A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic Pathways.
Topics: Caffeine; Cytochrome P-450 Enzyme System; Diazepam; Female; Granisetron; Humans; Metoprolol; Metronidazole; Midazolam; Models, Biological; Nifedipine; Ondansetron; Pharmaceutical Preparations; Pregnancy | 2018 |